🚀Why Most SaaS Founders Are Solving Problems Nobody Is Paying For

In 2014, a founder named Ben Congleton launched a product called Olark. It was a live chat tool for websites. Simple concept. Clean execution. The product worked exactly as described.

But for the first eight months, almost nobody paid for it.

Ben’s team could not understand why. The feedback was positive. Demo calls went well. Trial signups were steady. Users said they loved it. And then, at the end of the trial, they disappeared. Month after month, the same pattern. Enthusiasm followed by silence. The product was solving a problem people said they had. It just was not solving a problem they were willing to open their wallets for.

Then one of Ben’s early users sent an unsolicited email. It said three sentences. “We closed a $12,000 deal last week because of Olark. The customer had a question on our pricing page and we answered it in real time. Without the chat, they would have left.”

Ben read that email and understood immediately what had gone wrong for eight months.

He had been selling a communication tool. What he was actually selling was closed revenue. The moment Olark repositioned around that outcome, around the deals won and the revenue recovered, conversion rate changed. Retention changed. Expansion changed. The product had not changed by a single line of code. The problem it was solving had not changed either. What changed was the clarity around which version of the problem was the one people would actually pay to fix.

That distinction is the entire argument of this newsletter. And most SaaS founders have never fully resolved it.

Here is what is actually happening inside most stalled SaaS products.

The founder identified a real problem. That part is usually correct. People do experience the frustration, the inefficiency, the workflow gap that the product was built to address. The market research was not wrong. The customer interviews were not fabricated.

The error is more subtle. There is a significant difference between a problem people experience and a problem people prioritize. Between a frustration someone would like resolved and a pain someone will pay to eliminate. Most founders build for the first category and wonder why conversion is low. The market is not rejecting the product. It is ranking it below the threshold of urgency required to produce a purchase decision.

Understanding that distinction, and building a system to test it before committing engineering capital, is one of the highest-leverage Judgement decisions a technical founder can make. It costs almost nothing to diagnose. It saves months of misdirected development. And it is the difference between building a product the market appreciates and building a product the market pays for.

1. The Painkiller vs. Vitamin Problem Is Real, and You Need to Know Which One You Are

Every SaaS product sits somewhere on a spectrum between painkiller and vitamin. Painkillers solve urgent, costly, immediately felt problems. Vitamins improve outcomes that are real but not urgent, desirable but not critical, nice-to-have rather than must-have.

Painkillers get purchased. Vitamins get praised and cancelled.

The dangerous middle ground is the product that founders believe is a painkiller but the market treats as a vitamin. This misclassification is not a product problem. It is a diagnosis problem. And it is more common than almost any other failure mode in early-stage SaaS.

Here is how to run the diagnosis in under an hour.

Ask your last ten trial users who did not convert one question. Not “what did you think of the product?” That question produces compliments. Ask this instead: “What specifically would have to be true about your situation for this to be the first tool you renewed without thinking twice?” The answers will sort into two categories. Some will describe circumstances that already exist in their current reality. Those are your buyers. Others will describe hypothetical future states, team growth they have not hit yet, problems they expect but have not felt, use cases they are planning but not running. Those are your vitamin customers. They are not wrong about the product. They are just not in enough pain yet to prioritize it.

This single question, run consistently across every churned trial, produces a map of the exact circumstances that convert appreciation into purchase. That map is your ICP with precision you cannot get from firmographic data alone.

Intercom learned this distinction the hard way and then systematically profited from it. In their early growth phase between 2012 and 2014, they had strong adoption among early-stage startups who loved the product conceptually but churned at high rates because the problem Intercom solved, customer communication at scale, was not yet urgent at their company size. The pain was real. It was just future pain, not present pain.

Intercom’s response was not to build more features. It was to recalibrate their acquisition motion toward companies that were already experiencing the pain at scale, specifically companies with 50 or more active users where communication was already breaking down. Same product. Same price. Different urgency profile. Retention improved dramatically within two quarters of the shift because they stopped selling a future solution to people who had a present indifference.

2. The Willingness-to-Pay Test: Three Methods That Reveal the Truth in 72 Hours

Surveys do not measure willingness to pay. They measure willingness to say yes in a low-stakes environment. The only reliable signal of real payment intent is behavior under conditions that carry actual consequence.

Here are three methods ranked by signal reliability.

Method one: The Pre-Sale Email.

Write a single cold email to 25 prospects who fit your ICP precisely. Describe the problem your product solves in one sentence. Describe the outcome in one sentence. State a price. Then ask one question: “If this solved the problem exactly as described, would you be willing to put down a deposit to secure early access?”

Do not hedge the price. Do not offer a discount. Do not say “starting from.” Name the number.

A response rate of 15% or higher, defined as genuine interest in the deposit arrangement rather than a polite reply, is a strong willingness-to-pay signal. Below 5% means either the problem is not urgent enough, the price is not calibrated to the value, or the prospect list is wrong. Each of those is a solvable diagnosis. What you cannot solve is the ambiguity of a survey that asked “would you pay for this?” and received enthusiastic agreement from people who will never open their wallets.

Method two: The Consulting Bridge.

Before the product exists at scale, offer to solve the problem manually for three to five prospects at a price point that reflects the full software value. Not a discounted consulting rate. The actual price you intend to charge when the software does the same thing automatically.

If prospects pay for the manual version, the problem is real, the value is confirmed, and the price is validated in a single transaction. You have also spent time solving the problem alongside a real customer, which generates more precise product requirements than any interview protocol ever will.

This is exactly how Stripe validated their early market. Before the API was refined and scalable, Patrick and John Collison were manually onboarding merchants, sitting with founders at their laptops, walking them through payment integration in person. They were not doing this because they lacked engineering resources. They were doing it because manual delivery at real prices is the cleanest possible validation that a market will pay for a solution.

The product came after the validation. Not before.

Method three: The Friction Upgrade Test.

If you already have a free tier or trial, introduce a single friction point that requires a paid upgrade to resolve. Not a feature gate. A workflow gate. A moment in the core use case where the natural next action requires a payment to proceed.

Measure what percentage of users hit that gate and convert versus abandon. An abandonment rate above 85% at the gate is a signal that the value delivered before the gate was not sufficient to make the upgrade feel inevitable. A conversion rate above 20% at the gate is a strong signal that the product is solving a problem at the urgency level required for purchase behavior.

This test does not require a product rebuild. It requires one strategic placement of a conversion moment inside your existing flow, instrumented with event tracking, and run for 30 days before drawing conclusions.

3. The Problem Stack: Why Founders Solve the Wrong Layer of the Right Problem

There is a second dimension to this that goes deeper than painkiller versus vitamin. Even when a founder has correctly identified an urgent, paying problem, they frequently build the solution at the wrong layer of that problem.

Every real business problem has multiple layers. There is the surface symptom, the operational friction, and the financial consequence. Most SaaS products are built at the surface symptom layer because that is the layer customers describe in interviews. It is also the layer with the lowest willingness to pay, because surface symptoms are tolerable. Financial consequences are not.

Consider project management software. The surface symptom is disorganized tasks. The operational friction is missed deadlines and duplicated work. The financial consequence is delayed product launches, lost client contracts, and headcount inefficiency.

A product positioned against disorganized tasks competes in a crowded market of tolerated solutions. A product positioned against delayed launches and lost contracts is competing against a financial consequence that has a measurable dollar value. The pricing power, the urgency, and the retention characteristics of the second positioning are categorically different from the first.

Asana understood this transition more deliberately than almost any other project management tool. Their early positioning was organized around tasks and projects, the surface symptom layer. Their evolution toward “work management for teams” and eventually toward “connecting work to company-wide goals” was a deliberate climb up the problem stack, from surface symptom toward financial consequence. Each repositioning unlocked a higher willingness-to-pay segment and a longer retention profile because the problem being solved was increasingly expensive to leave unsolved.

A practical AI prompt to run this analysis on your own product: Open Claude and run this prompt: “Here is how I currently describe the problem my SaaS product solves: [your current positioning]. Help me map this problem across three layers: the surface symptom layer, which is what users notice and complain about; the operational friction layer, which is the workflow breakdown caused by the symptom; and the financial consequence layer, which is the measurable business cost of leaving the problem unsolved. Then rewrite my positioning statement at each layer and estimate which layer is most likely to produce the highest willingness to pay from a B2B buyer.” The output will show you immediately whether your current positioning is at the layer your market will pay urgently to resolve or at the layer they will appreciate and eventually cancel.

4. The Revenue Conversation You Are Not Having

There is a behavior pattern among technical founders that is worth naming directly. Because it is costing real revenue in real time.

Most technical founders are deeply uncomfortable asking prospects about money. About budget. About what they are currently paying to solve this problem through other means. About how much the problem costs them in lost revenue, wasted hours, or failed outcomes every quarter.

That discomfort is understandable. It does not feel like a product conversation. It feels like a sales conversation. And many founders drew a sharp line between the two when they started their company.

That line is a structural disadvantage.

The willingness-to-pay conversation is not a sales tactic. It is the most important product research conversation you can have. When a prospect tells you they are currently paying $3,000 per month for a manual process that your software could automate for $500 per month, that is not a sales lead. That is a pricing signal, a positioning insight, and a product validation wrapped in a single sentence.

When a prospect tells you the problem you solve costs their company approximately $200,000 per year in lost productivity, you now know that your $200 per month pricing is not a deal. It is an embarrassment. You are charging $2,400 per year to solve a $200,000 problem. That is a 1% value capture rate. The market will pay far more than you are asking. And you would never know that without the conversation.

Build the revenue conversation into every customer interaction. Not as a closing move. As a diagnostic question that informs your product, your pricing, and your positioning simultaneously.

Ask it in these words: “What is the cost to your business of leaving this problem unsolved for another twelve months?” Then stop talking. Let the number arrive. Whatever number they give you is your pricing anchor. And if they cannot name a number, the problem is still at the surface symptom layer. You have more climbing to do before the product is positioned where urgency lives.

Ben Congleton did not build a better live chat tool to fix Olark’s conversion problem. He found the layer of the problem that buyers actually paid for. Closed revenue. Not conversation volume.

Intercom did not build new features to fix their churn problem. They found the urgency profile, the company size and growth stage where the pain was present rather than future.

Stripe did not run surveys to validate their market. They delivered the solution manually at real prices until the payment behavior confirmed that the problem was worth solving at scale.

The pattern across all three is the same. They stopped building toward problems people described and started building toward problems people paid to solve. That recalibration, made early and made systematically, is the difference between a product with enthusiastic trial users and a product with compounding revenue.

Your product is probably solving a real problem. The question worth asking this week, with genuine rigor and without the comfort of positive survey responses, is whether it is solving the layer of that problem that your market will consistently, urgently, and willingly pay to resolve.

If the answer is not immediately obvious, that is not a failure. It is a diagnostic. And the three methods in this newsletter give you the tools to resolve it before your next sprint planning session commits more engineering capital to the wrong answer.

The Startup Growth OS is built for founders who are ready to move from building what feels right to building what the market has already confirmed it will pay for. Judgement is where that shift begins. And it compounds through every pillar that follows.

Sam Femi
Seamless Life HQ

P.S – Building a product is hard, but building something nobody wants to pay for is heartbreaking. Yet, it’s the #1 reason SaaS startups fail. If you want to make sure you aren’t wasting months on a feature or product that will get zero traction – Click here